The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP).

Saved in:
Bibliographic Details
Title: The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP).
Authors: Barrett JS; Aridhia Digital Research Environment, Glasgow, UK. barrett@aridhia.com.; Aridhia Bioinformatics, 163 Bath Street, Glasgow, G2 4SQ, United Kingdom. barrett@aridhia.com., Betourne A; Critical Path Institute, Tucson, AZ, USA., Walls RL; Critical Path Institute, Tucson, AZ, USA., Lasater K; Aridhia Digital Research Environment, Glasgow, UK., Russell S; Aridhia Digital Research Environment, Glasgow, UK., Borens A; Aridhia Digital Research Environment, Glasgow, UK., Rohatagi S; Critical Path Institute, Tucson, AZ, USA., Roddy W; Critical Path Institute, Tucson, AZ, USA.
Source: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2023 Dec; Vol. 50 (6), pp. 507-519. Date of Electronic Publication: 2023 May 02.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101096520 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-8744 (Electronic) Linking ISSN: 1567567X NLM ISO Abbreviation: J Pharmacokinet Pharmacodyn Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-8744
DOI:10.1007/s10928-023-09859-7